These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26131097)

  • 1. Expression of phosphorylated Akt/mTOR and clinical significance in human ameloblastoma.
    Li N; Sui J; Liu H; Zhong M; Zhang M; Wang Y; Hao F
    Int J Clin Exp Med; 2015; 8(4):5236-44. PubMed ID: 26131097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
    Li TJ; Cui J
    Asian Pac J Trop Med; 2013 Aug; 6(8):640-3. PubMed ID: 23790336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of WNT1 in ameloblastoma and its significance.
    Wang GN; Zhong M; Chen Y; Ji J; Gao XQ; Wang TF
    Oncol Lett; 2018 Aug; 16(2):1507-1512. PubMed ID: 30008830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of eukaryotic translation initiation factor 3 subunit a promotes cell survival in ameloblastoma.
    Ding Z; Liu J; Wang J; Huang B; Zhong M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Aug; 128(2):146-153. PubMed ID: 31078505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic significance of AKT, mTOR, and GSK3β proteins in oral squamous cell carcinoma-affected patients.
    Matsuo FS; Andrade MF; Loyola AM; da Silva SJ; Silva MJB; Cardoso SV; de Faria PR
    Virchows Arch; 2018 Jun; 472(6):983-997. PubMed ID: 29713826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.
    Moraes JK; Wagner VP; Fonseca FP; Amaral-Silva GKD; de Farias CB; Pilar EFS; Gregianin L; Roesler R; Vargas PA; Martins MD
    Oral Dis; 2019 Nov; 25(8):1925-1936. PubMed ID: 31498938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of ICAM-1 and VCAM-1 in human ameloblastoma and odontogenic keratocyst].
    Wang J; Zhong M; Zhang LZ; Wang Y; Wang ZY
    Shanghai Kou Qiang Yi Xue; 2003 Aug; 12(4):273-6. PubMed ID: 14966640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis.
    Martins F; de Sousa SC; Dos Santos E; Woo SB; Gallottini M
    J Oral Pathol Med; 2016 Nov; 45(10):746-752. PubMed ID: 26991907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity.
    Chaisuparat R; Limpiwatana S; Kongpanitkul S; Yodsanga S; Jham BC
    J Oral Pathol Med; 2016 Sep; 45(8):581-5. PubMed ID: 26775690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of hTERT, c-fos and c-jun in ameloblastoma].
    Zhong M; Liu JD; Wang J; Liu J; Li L; Hou L; Zhang B
    Shanghai Kou Qiang Yi Xue; 2006 Oct; 15(5):461-5. PubMed ID: 17348214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of survivin in ameloblastoma and its clinical significance].
    Li L; Zhang XL; Wang P; Liu Y
    Shanghai Kou Qiang Yi Xue; 2014 Aug; 23(4):481-4. PubMed ID: 25338803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAcylation in oral squamous cell carcinoma.
    Kongkaew T; Aung WPP; Supanchart C; Makeudom A; Langsa-Ard S; Sastraruji T; Chaiyarit P; Krisanaprakornkit S
    J Oral Pathol Med; 2018 Mar; 47(3):260-267. PubMed ID: 29327476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
    AbdulMajeed AA; Dalley AJ; Farah CS
    Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between clincopathological characteristics and hTERT expression as well as telomere length in ameloblastoma.
    Hao F; Liu J; Zhong M; Wang J; Liu J
    Int J Clin Exp Pathol; 2017; 10(8):8647-8653. PubMed ID: 31966722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development.
    Ding YM; Dong JH; Chen LL; Zhang HD
    Oncol Rep; 2009 Apr; 21(4):983-7. PubMed ID: 19287997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
    Lin F; Zhang PL; Yang XJ; Prichard JW; Lun M; Brown RE
    Ann Clin Lab Sci; 2006; 36(3):283-93. PubMed ID: 16951269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC1 mucin in potentially malignant disorders, oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study.
    Kumar MH; Sanjai K; Kumarswamy J; Keshavaiah R; Papaiah L; Divya S
    J Oral Maxillofac Pathol; 2016; 20(2):214-8. PubMed ID: 27601811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.